Fighting Prostate Cancer with The MIL-38 MiStatTM in vitro diagnostic test: Brad Walsh, CEO, Minomic




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Fighting Prostate Cancer with The MIL-38 MiStatTM in vitro diagnostic test: Brad Walsh, CEO, Minomic
Released on: November 11, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this interview, filmed at BIO Europe in Turin, Fintan Walton talks to Brad Walsh, CEO of Australian company Minomic.
  • Summary
  • Transcript
  • Participants
  • Company
In this interview, filmed at BIO Europe in Turin, Fintan Walton talks to Brad Walsh, CEO of Australian company Minomic. Minomic are developing an exciting new, non-invasive test for Prostate Cancer by detecting a protein that is present in cancer cells. It's shaping up to be more effective than existing tests and is in the late development stage. They discuss how the Minomic test is more accurate than a PSA and will be performed in standard pathology labs, meaning those who need treatment will get it sooner, and those who don't need not suffer the trauma of false positives, nor add costs to the system.
In this interview, filmed at BIO Europe in Turin, Fintan Walton talks to Brad Walsh, CEO of Australian company Minomic. Minomic are developing an exciting new, non-invasive test for Prostate Cancer by detecting a protein that is present in cancer cells. It's shaping up to be more effective than existing tests and is in the late development stage. They discuss how the Minomic test is more accurate than a PSA and will be performed in standard pathology labs, meaning those who need treatment will get it sooner, and those who don't need not suffer the trauma of false positives, nor add costs to the system.
Brad Walsh
Minomic
Minomic